Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure
- Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies
- Up to 80% of patients may need multiple medications to help them reach blood pressure goals
- Single-pill combinations offer effective, ...
DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
...iation, particularly for TSAT and ferritin. Hb and
hct were affected by the day of the week blood was dra...e obtained the first dialysis day of the week. Hb,
hct and Ret-H e /CHr values were measured using a Sysm...chieve clinically meaningful accuracy and that HB,
hct and reticulocyte Hb (Ret-H e or CHr) were useful ...
Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
... - Exforge
hct combines a proven calcium channel blocker, angiote...) in one pill
- In a clinical trial, Exforge
hct demonstrated significantly greater reductions in s...essure and many need three or more
- Exforge
hct can help appropriate patients reach BP goals; offe...
Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008
...ons with peak widths less than 5 sec. The control by Bruker's Hystar™ software supports all proteomics applications on the maxis, micrOTOF-Q II,
hct ion trap, Flex MALDI and apex FTMS instrument series for complete, turn-key LC/MS/MS solutions. The new Bruker mass spectrometry products and applicat...
Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment
...end of March
2014, whereby Forest will receive a gradual reduction on profit percentage
from its partner Daiichi Sankyo related to Benicar and Benicar
hct sales.
However, during this period the Benicar profit received will no longer be
impacted by salesforce expense as the Company will reallocate those d...
JCI table of contents: Feb. 21, 2008
...c stem cell transplantation (HCT). However, little is known about effective
hct approaches to treating individuals with solid tumors. In a new study, Richa...olleagues, at the National Institutes of Health, Bethesda, have outlined an
hct approach for the treatment of metastatic kidney cancer that caused tumor re...
DaVita 4th Quarter 2007 Results
...t/V > 1.2 94.4% 93.6% 92.9% Patients with albumin >/= 3.5 83.7% 82.9% 84.0% Patients with
hct >/= 33 82.4% 82.8% 84.7%
(1) These are non-GAAP financial measures. For a reconciliation of these non-G...
HCT in Medical Technology
Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage
2 Patients Compared With Amlodipine + Benazepril
Comparison of BENICAR
HCT 40/12.5 and 40/25 mg/day and Amlodipine +
Benazepril 5/20 and 10/20 mg/day Presented at American Society of
Hypertension Twenty-Second Annual Scientific Meeting
PARSIPPANY, N.J., May 21, 2007 /PRNewswire/ -- New data
presented today at the American Society of Hypertension...
FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
...gs to achieve their blood pressure goals. Tekturna
hct is a single-pill combination of Tekturna((R)) (ali...edications.
The FDA approval of Tekturna
hct as initial therapy was based on clinical trial dat...pleased the FDA recognizes the benefit of Tekturna
hct for the first-line treatment of patients with mode...
Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
...eotech is developing based upon its first-in-class
hct platform. A total of 60 patients were enrolled in ...
DuraTech is the leading product in Osteotech's
hct platform, which is based on Osteotech's breakthrou...ntroduce additional tissue products based upon its
hct platform over the next several years that address ...
New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
...iSILVER study found that BENICAR (R) and BENICAR
hct (R) provided a mean reduction in 24-hour ambulato...sure (BP)-lowering efficacy of BENICAR and BENICAR
hct in patients age 65 and older with mild to moderate...e, heart attack and stroke.(2) BENICAR and BENICAR
hct are indicated for the treatment of hypertension. T...
New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
...nation with other
antihypertensive agents. BENICAR
hct is not indicated for initial therapy.
BENICAR and BENICAR
hct have not been FDA approved for other indications
s...salt retention and increased blood volume.
BENICAR
hct combines BENICAR with the diuretic hydrochlorothia...
New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
...lood pressure (BP) of BENICAR
hct (placebo: 43.1%).
- Six out of 10 (cumulative 60....e to achieve a BP of BENICAR
hct (placebo: 6.9%).
PARSIPPANY, N.J., May 14 /PRNew...ed the ability of a regimen of
BENICAR and BENICAR
hct to lower blood pressure beyond 140/90 mm Hg to the...
NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
...Ox is targeting the
therapeutic areas of inflammation and cardio-metabolic disease. Resources
are focused on two lead compounds, naproxcinod (formerly
hct 3012); in
phase 3 development for the treatment of signs and symptoms of
osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes.
NicOx has str...
NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
...Ox is targeting the
therapeutic areas of inflammation and cardio-metabolic disease. Resources
are focused on two lead compounds, naproxcinod (formerly
hct 3012); in
phase 3 development for the treatment of signs and symptoms of
osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...
NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology
...Ox is targeting the
therapeutic areas of inflammation and cardio-metabolic disease. Resources
are focused on two lead compounds, naproxcinod (formerly
hct 3012), in
phase 3 development for the treatment of signs and symptoms of
osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...
NicOx' Naproxcinod ABPM Data Presented at American Heart Association
...Ox is targeting the
therapeutic areas of inflammation and cardio-metabolic disease. Resources
are focused on two lead compounds, naproxcinod (formerly
hct 3012); in
phase 3 development for the treatment of signs and symptoms of
osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...
HCT in Medical Products
STAT-CRIT HCT Instrument
Description: STAT-CRIT is a rapid, one-step system for measuring hematocrit....
Company:Inverness Point of Care
STAT-CRIT Hct Analyzer
Description: STAT-CRIT is a rapid, one-step system for measuring hematocrit....
Company:Wampole Laboratories
SafeCrit® Microhematocrit Tubes
Description:... easy to read SafeCrit plastic tubes, plain or heparinized. These tubes feature rapid capillary action and have a two-year shelf life. For use in RH12
hct rotor....
Company:Iris Sample Processing (formerly StatSpin, Inc.)
CritSpin Microhematocrit Centrifuge
Description:...ge of important benefits: - 2 minute spin, complete cell packing - Meets NCCLS standards - Read tubes in the rotor, less handling, less risk - Digital
hct display reduces chance of error - Accepts glass or SafeCrit plastic tubes - Tube balancing not required, vibration free operation.
Approval: C...
Company:Iris Sample Processing (formerly StatSpin, Inc.)
HCT in Biological Technology
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
...o received allogeneic hematopoietic cell transplants (HCT). Non-infectious inflammation of the lung is a common and potentially fatal complication of
hct that decreases the exchange of oxygen and carbon dioxide between the lung and blood and, in its severe form, may present as interstitial pneumonitis. ...
Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
...ring which Forest will have a
residual participation in Benicar and Benicar
hct profits, but will not be
actively promoting those products. The result of t...mportant additional
resources to build our franchise of Benicar and Benicar
hct into
significant products in the antihypertensive market while we built our...
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
...r blocker
combination product, all indicated for the treatment of hypertension.
* Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar
hct are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Dar...
Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
... in the United
States under license from Merz Pharma GmbH & Co. KGaA of Germany.
*Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar
hct are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Darmst...
Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure
... - Tekturna
hct combines first approved direct renin inhibitor wit...monly-used high
blood pressure medicines. Tekturna
hct is approved for patients not
controlled by either ...Pennsylvania Hospital in Pittsburgh, PA. "Tekturna
hct offers
patients an effective new treatment option ...
One of Nation's Oldest Blood Services Providers Turns to Sysmex America
...ct fit for the blood
processing center. The XE-2100D has an easy-to-use operating system and an
extended platelet linearity of up to 5,000 x 10/ul and
hct linearity up to
75%. Sysmex's state-of-the-art Interlaboratory Quality Control Program
features a multi-level, all inclusive quality control material....
NicOx Opens U.S. Headquarters in New Jersey
...Ox is targeting the
therapeutic areas of inflammation and cardio-metabolic disease. Resources
are focused on two lead compounds, naproxcinod (formerly
hct 3012); in
phase 3 development for the treatment of signs and symptoms of
osteoarthritis, and NCX 4016, in phase 2 for type 2 diabetes. NicOx has stra...
Schwartz leaves Merge board; will launch healthcare technology investment fund
...iding business development assistance to the company beyond his previously disclosed departure date of Sept. 1.
"While the decision to launch a new
hct fund requires me to resign from the board of directors, I plan to continue assisting the company in various new business development activities. It ha...
Analysis of Microarray Data
...man Cancer Institute
cDNA microarray. mRNA or aRNA (2 g) was reverse transcribed in
the presence of random ninemers and Cy dyes.
hct 116 samples were
labeled with Cy5-dCTP while RKO cells were labeled with Cy3-dCTP. Analysis
of the microarray data was carried o...